Krishna Gorti

Dr. Gorti has a rich and diverse background including roles in corporate development and investor relations, as an investment analyst covering biotechnology companies, as a physician trained in otolaryngology & head and neck surgery, and as a clinical and translational researcher.

In his previous tenure with The Medicines Company, he served as Senior Vice President of Investor Relations and played an integral role in value-building initiatives, as well as working in earlier roles in business development and strategy.

Prior to roles with biopharmaceutical companies, Gorti was a biotechnology industry equity research analyst (sell side) with leading financial institutions, including JP Morgan, Piper Jaffray and Rodman & Renshaw.